REGISITA D 100/10 Tablet 10's tofacitinib XR Safety Advice: Not for severe

Safety Advice: Not for severe GI disease

or vitamin deficiency

About: Prevents cardiovascular events in high-risk patients by lowering cholesterol and thinning blood

Side Effects: Occasional mild irritation or dryness

Safety Advice: Not for smokers over 35

REGISITA D 100/10 Tablet 10's tofacitinib XR Safety Advice: Not for severeAbout: REGISITA D is used for type 2 diabetes management, combining Dapagliflozin and Sitagliptin. Usage Instructions: Take one tablet daily with food. Benefits: Controls blood glucose, helps remove excess sugar via urine. How it Works: Dapagliflozin promotes glucose excretion; Sitagliptin enhances insulin secretion. Side Effects: Urinary infection, sore throat. Safety Advice: Monitor blood sugar and kidney function. Storage: Store below 30C.